Derek Hicks - EVP, Chief Business Officer at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Business Officer
Stock Symbol
NTLA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

Derek Hicks - trading volume in the past year for Intellia Therapeutics, Inc.

Holdings reported by Derek Hicks for Intellia Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 66.4K $2.19M $32.99 Mar 1, 2024 Direct
Stock Option (right to buy) 42.4K Mar 1, 2024 Direct Common Stock

Transactions reported by Derek Hicks for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.